ARDEN, HEREFORDSHIRE & WORCESTERSHIRE PRIMARY EYECARE LTD.


Directors	Ravinder Cheema
	Sanha Aneez Iqbal
	Francesca Maria Marchetti
	Jason Christopher Rice


Registered Address	2 Woodbridge Street
	London
	EC1R 0DG


Registered Number	06723599 (England and Wales)

Balance Sheet as at
31 October 2025

	Notes	2025		2024
		£	£	£	£
Current assets
Debtors	3	187,486		70,391
Cash at bank and on hand		39,852		42,529
		227,338		112,920
Creditors amounts falling due within one year	4	(185,889)		(88,995)
Net current assets (liabilities)			41,449		23,925
Total assets less current liabilities			41,449		23,925
Net assets			41,449		23,925
Capital and reserves
Profit and loss account			41,449		23,925
Reserves			41,449		23,925

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 12 July 2026, and are signed on its behalf by:

Jason Christopher Rice
Director
Registered Company No. 06723599

ARDEN, HEREFORDSHIRE & WORCESTERSHIRE PRIMARY EYECARE LTD.

Notes to the Financial Statements
for the year ended 31 October 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by guarantee and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

	Basis of preparation
	The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The following principal accounting policies have been applied:

	Turnover policy
	Turnover comprises revenue recognised by the company in respect of services supplied during the year.

	Current taxation
	Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Current taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

	Financial instruments
	The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	0		0

3.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	-	921
Other debtors	-	2,462
Prepayments and accrued income	187,486	67,008
Total	187,486	70,391

4.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	77,998	66,836
Other creditors	106,251	20,519
Accrued liabilities and deferred income	1,640	1,640
Total	185,889	88,995

5.	Further information regarding the company's financial position
	The company is a company limited by guarantee, not having share capital. Every member of the company who has subscribed to the company's Articles and Memorandum of Association undertakes to contribute to the assets of the company in the event of the company being wound up while they are a member, or within one year after they cease to be a member, for payment of the debts and liabilities of the company contracted before they cease to be a member, and of the costs, charges and expenses of the winding up and for the adjustment of the rights of the contributories amongst themselves, as may be required not exceeding £10. The sole member of the company is Primary Eyecare Holdings Limited, registered in England.

Further information regarding the company's financial position

The company is a company limited by guarantee, not having share capital. Every member of the company who has subscribed to the company's Articles and Memorandum of Association undertakes to contribute to the assets of the company in the event of the company being wound up while they are a member, or within one year after they cease to be a member, for payment of the debts and liabilities of the company contracted before they cease to be a member, and of the costs, charges and expenses of the winding up and for the adjustment of the rights of the contributories amongst themselves, as may be required not exceeding £10. The sole member of the company is Primary Eyecare Holdings Limited, registered in England.